Soru

Zorluk: OrtaBipolar and Related Disorders

A 22-year-old male college student is brought to the psychiatric emergency department by his parents due to severe depression. For the past four weeks, he has isolated himself in his room, slept up to 15 hours a day, eaten very little, and frequently expressed feelings of worthlessness. He admits to having passive thoughts of suicide but denies any active plan. Review of his medical record reveals a prior psychiatric hospitalization three months ago. During that admission, he presented with a 4-week history of sleeping only 2 hours per night, rapid and pressured speech, excessive spending, and experiencing auditory hallucinations of 'angels' telling him he was chosen for a divine mission. His symptoms resolved completely during that hospitalization with the temporary use of haloperidol, and he has not taken any medications since discharge. Vital signs are within normal limits, and the physical examination is unremarkable. Which of the following is the most appropriate next step in the management of this patient?

  1. Initiate quetiapineCevap
  2. B
    Initiate sertraline
  3. C
    Initiate venlafaxine
  4. D
    Initiate fluoxetine and phenelzine
  5. E
    Initiate haloperidol

Cevap

Initiate quetiapine
The patient has a history of a distinct period of abnormally increased energy, decreased need for sleep, pressured speech, and psychosis (grandiose hallucinations) lasting 4 weeks. This clearly meets the criteria for a manic episode, establishing the diagnosis of Bipolar I Disorder. His current presentation of profound low mood, hypersomnia, and suicidal ideation represents an acute major depressive episode. The treatment of acute bipolar depression requires agents specifically proven effective for this phase without inducing a manic switch. Quetiapine is a second-generation antipsychotic with strong clinical evidence and FDA approval for the treatment of acute bipolar depression.

Adım Adım Çözüm

1
Analyze the patient's current clinical presentation.
The patient is experiencing a severe major depressive episode characterized by hypersomnia, anhedonia, feelings of worthlessness, and suicidal ideation lasting for 4 weeks.
Establishing the current mood state is essential for guiding targeted pharmacotherapy.
2
Review the psychiatric history to establish the primary diagnosis.
The patient had a previous 4-week episode of a decreased need for sleep, pressured speech, impulsivity, and grandiose hallucinations.
A history of a distinct manic episode (abnormally elevated mood and energy lasting 1 week or more) establishes a definitive diagnosis of Bipolar I Disorder, even if psychotic features are present.
3
Select the appropriate evidence-based treatment for acute bipolar depression.
First-line treatments include atypical antipsychotics such as quetiapine or lurasidone, or the anticonvulsant lamotrigine.
Traditional antidepressant monotherapy must be avoided in bipolar depression due to the severe risk of inducing a manic switch.

Anahtar Kavram

Bipolar I disorder, currently in a depressed episode, is treated with medications specifically proven effective for bipolar depression (e.g., quetiapine, lurasidone, lamotrigine). Traditional antidepressant monotherapy is contraindicated due to the risk of a manic switch.
Bu soruyu puanla